Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)
- Status
- TERMINATED
- Phase
- N/A
Duloxetine for the Treatment of Generalized Anxiety Disorder
- Status
- COMPLETED
- Phase
- PHASE3
First Presentation of Parkinson Disease Patients to Neurologist
- Status
- COMPLETED
- Phase
- N/A
A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I
- Status
- COMPLETED
- Phase
- PHASE3
12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE2
Influenza Vaccination in Immunocompromized Patients
- Status
- COMPLETED
- Phase
- PHASE4
12 / 48 wk Pivotal PFT vs PBO in COPD II
- Status
- COMPLETED
- Phase
- PHASE3
12 / 48 Week Pivotal PFT vs PBO in COPD I
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)
- Status
- COMPLETED
- Phase
- PHASE3
Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study of BI 831266 in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1